Short Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Decreases By 29.0%

Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report) was the target of a large decline in short interest in February. As of February 28th, there was short interest totalling 15,700 shares, a decline of 29.0% from the February 13th total of 22,100 shares. Currently, 0.1% of the company's stock are short sold. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Basilea Pharmaceutica Price Performance

Shares of OTCMKTS BPMUF remained flat at $52.83 during mid-day trading on Thursday. The firm's 50 day moving average is $52.83 and its 200-day moving average is $52.51. Basilea Pharmaceutica has a 52 week low of $38.60 and a 52 week high of $52.83. The company has a quick ratio of 3.27, a current ratio of 4.10 and a debt-to-equity ratio of 5.70.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.